Document is current
Any future updates will be listed below
-
Authors
García-Hidalgo, María C.
Mota-Martorell, Natàlia
González, Jessica
Benítez, Iván D.
Company-Marín, Idoia
Jové, Mariona
Barbé, Ferran
Amigó, Núria
Pamplona, Reinald
de Gonzalo-Calvo, David https://orcid.org/0000-0003-2240-3532
Torres, Gerard
- License Information
-
More Information
Article History
Received: 11 June 2025
Accepted: 28 December 2025
First Online: 20 January 2026
Declarations
:
: The medical ethics committee of Hospital Universitari Arnau de Vilanova approved the protocol (CEIC/2273). The present study was performed in full compliance with the Declaration of Helsinki. The patients were provided with written information indicating the nature and goals of the study and signed an informed consent form. Patient and sample data were registered in a database with access restricted to authorized personnel. To ensure that sex, and other diversity dimensions (such as age) are properly accounted for, the study includes balanced participant selection. No exclusion criteria were set based on sex, age ethnic or cultural background.
: Not applicable.
: NA is a stock owner of Biosfer Teslab and has a patent related to the lipoprotein profiling described in the present manuscript. The rest of authors declare not to have any conflicts of interest that may be considered to influence directly or indirectly the content of the manuscript.
